Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""The Lancet. Infectious diseases [Lancet Infect Dis] NLMUID: 101130150"" wg kryterium: JN


Tytuł :
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Autorzy :
Sissoko MS; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Healy SA; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Katile A; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Zaidi I; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Hu Z; Biostatistical Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Kamate B; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Samake Y; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Sissoko K; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Mwakingwe-Omari A; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Center for Vaccine Research, GlaxoSmithKline, Rockville, MD, USA.
Lane J; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Imeru A; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Mohan R; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Thera I; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Guindo CO; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Dolo A; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Niare K; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Koïta F; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Niangaly A; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Rausch KM; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Zeguime A; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Guindo MA; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Bah A; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Abebe Y; Sanaria, Rockville, MD, USA.
James ER; Sanaria, Rockville, MD, USA.
Manoj A; Sanaria, Rockville, MD, USA.
Murshedkar T; Sanaria, Rockville, MD, USA.
Kc N; Sanaria, Rockville, MD, USA; Protein Potential, Rockville, MD, USA.
Sim BKL; Sanaria, Rockville, MD, USA; Protein Potential, Rockville, MD, USA.
Billingsley PF; Sanaria, Rockville, MD, USA.
Richie TL; Sanaria, Rockville, MD, USA.
Hoffman SL; Sanaria, Rockville, MD, USA.
Doumbo O; Malaria Research and Training Center, Mali-NIAID ICER, University of Science, Techniques and Technologies of Bamako, Mali.
Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 18. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Assessment of experimental malaria vaccine induced protection in pre-exposed populations.
Autorzy :
Daubenberger C; Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 18. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis.
Autorzy :
Dhana A; Department of Medicine, University of Cape Town, Cape Town, South Africa.
Hamada Y; Centre for International Cooperation and Global Tuberculosis Information, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan; Institute for Global Health, University College London, London, UK.
Kengne AP; Non-communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.
Kerkhoff AD; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, CA, USA.
Rangaka MX; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Institute for Global Health, University College London, London, UK.
Kredo T; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Baddeley A; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Miller C; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Singh S; Global HIV, Hepatitis and STIs Programme, World Health Organization, Geneva, Switzerland.
Hanifa Y; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Fielding K; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Affolabi D; Laboratoire de Référence des Mycobactéries, Cotonou, Benin.
Merle CS; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland.
Wachinou AP; National Hospital for Tuberculosis and Pulmonary Diseases, Cotonou, Benin.
Yoon C; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Tuberculosis, University of California, San Francisco, CA, USA.
Cattamanchi A; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Tuberculosis, University of California, San Francisco, CA, USA.
Hoffmann CJ; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Martinson N; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Johns Hopkins University Center for Tuberculosis Research, Baltimore, MD, USA.
Mbu ET; Bamenda Regional Hospital HIV Treatment Center, Bamenda, Cameroon.
Sander MS; Tuberculosis Reference Laboratory Bamenda, Bamenda, Cameroon.
Balcha TT; Clinical Infection Medicine, Lund University, Malmö, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden.
Skogmar S; Department of Translational Medicine, Lund University, Malmö, Sweden.
Reeve BWP; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.
Theron G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.
Ndlangalavu G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.
Modi S; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Cavanaugh J; US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Swindells S; University of Nebraska Medical Center, Omaha, NE, USA.
Chaisson RE; Johns Hopkins University Center for Tuberculosis Research, Baltimore, MD, USA.
Ahmad Khan F; McGill International Tuberculosis Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Howard AA; ICAP at Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Wood R; Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Thit SS; Department of Medicine, University of Medicine 2, Yangon, Yangon Division, Myanmar.
Kyi MM; Department of Medicine, University of Medicine 2, Yangon, Yangon Division, Myanmar.
Hanson J; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Drain PK; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Shapiro AE; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.
Kufa T; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.
Churchyard G; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; The Aurum Institute, Parktown, South Africa.
Nguyen DT; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Graviss EA; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA.
Bjerrum S; Department of Clinical Research, Infectious Diseases, University of Southern Denmark, Odense, Denmark.
Johansen IS; Research Unit for Infectious Diseases, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
Gersh JK; University of Washington, Seattle, WA, USA.
Horne DJ; Department of Medicine, Division of Infectious Diseases, University of Washington, Seattle, WA, USA.
LaCourse SM; Department of Medicine, Division of Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Global Health, Division of Infectious Diseases, University of Washington, Seattle, WA, USA.
Al-Darraji HAA; Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia.
Kamarulzaman A; Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia.
Kempker RR; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Tukvadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Barr DA; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Meintjes G; Department of Medicine, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Maartens G; Department of Medicine, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 17. Date of Electronic Publication: 2021 Nov 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.
Autorzy :
Ismail NA; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa; Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Omar SV; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa. Electronic address: .
Moultrie H; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Bhyat Z; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Conradie F; Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Enwerem M; Amity Health Consortium, Johannesburg, South Africa.
Ferreira H; Klerksdorp/Tshepong Hospital Complex, Multi-drug resistant-Extensively-drug resistant Tuberculosis Unit, North West Provincial Department of Health, Perinatal HIV Research Unit, Klerksdorp, South Africa.
Hughes J; Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Joseph L; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Kock Y; Drug-resistant Tuberculosis Directorate, National Department of Health, Pretoria, South Africa.
Letsaolo V; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Maartens G; Department of Medicine and Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Meintjes G; Department of Medicine and Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Ngcamu D; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Okozi N; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Padanilam X; Department of Health, Sizwe Tropical Disease Hospital, Johannesburg, South Africa.
Reuter A; Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa.
Romero R; District Clinical Specialist Team, Namakwa, South Africa.
Schaaf S; Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Te Riele J; Metro Tuberculosis Hospital Centre, Brooklyn Chest Hospital, Western Cape, South Africa.
Variava E; Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; Klerksdorp/Tshepong Hospital Complex, Multi-drug resistant-Extensively-drug resistant Tuberculosis Unit, North West Provincial Department of Health, Perinatal HIV Research Unit, Klerksdorp, South Africa.
van der Meulen M; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
Ismail F; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa.
Ndjeka N; Drug-resistant Tuberculosis Directorate, National Department of Health, Pretoria, South Africa.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 12. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Autorzy :
Goldstone SE; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: .
Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA.
Palefsky JM; Department of Medicine, University of California at San Francisco, CA, USA.
Lazcano-Ponce E; Instituto Nacional de Salud Pública, Santa María Ahuacatitlán, Cuernavaca, México.
Penny ME; Instituto de Investigación Nutricional, Lima, Peru.
Cabello RE; Asociación Via Libre, Lima, Peru.
Moreira ED Jr; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Brazilian Ministry of Health, Salvador, Bahia, Brazil.
Baraldi E; Trialtech Research Institute, Pretoria, South Africa.
Jessen H; Praxis Jessen(2) + Kollegen, Berlin, Germany.
Ferenczy A; McGill University Health Center, Montreal, QC, Canada.
Kurman R; Department of Gynecology and Obstetrics and Department of Pathology Johns Hopkins University, Baltimore, MD, USA.
Ronnett BM; Department of Gynecology and Obstetrics and Department of Pathology Johns Hopkins University, Baltimore, MD, USA.
Stoler MH; Department of Pathology, University of Virginia, Charlottesville, VA, USA.
Bautista O; Merck & Co, Kenilworth, NJ, USA.
Das R; Merck & Co, Kenilworth, NJ, USA.
Group T; Merck & Co, Kenilworth, NJ, USA.
Luxembourg A; Merck & Co, Kenilworth, NJ, USA.
Zhou HJ; MSD China, Beijing, China; Sun Yat-sen University, Guangzhou, China.
Saah A; Merck & Co, Kenilworth, NJ, USA.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 12. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The potential perils of a drug protection framework in tuberculosis.
Autorzy :
Furin J; Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA 02115, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 12. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
Autorzy :
Nasa P; NMC Speciality Hospital, Dubai, United Arab Emirates.
Azoulay E; Saint-Louis Teaching Hospital, APHP, University of Paris, Paris, France.
Chakrabarti A; Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Divatia JV; Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Jain R; Mahatma Gandhi Medical College and Hospital, Jaipur, India.
Rodrigues C; PD Hinduja National Hospital and Medical Research Centre, Mumbai, India.
Rosenthal VD; International Nosocomial Infection Control Consortium, Miami, FL, USA.
Alhazzani W; McMaster University, Hamilton, ON, Canada.
Arabi YM; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Bakker J; New York University Grossman School of Medicine, New York, NY, USA; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA; Erasmus University Medical Center, Rotterdam, Netherlands; Pontificia Universidad Catolica de Chile, Santiago, Chile.
Bassetti M; Department of Health Sciences, University of Genoa, Genoa, Italy.
De Waele J; Ghent University Hospital, Ghent, Belgium.
Dimopoulos G; Attikon University Hospital, Athens, Greece; National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
Du B; State Key Laboratory of Rare, Complex and Critical Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Einav S; Shaare Zedek Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
Evans L; University of Washington, Seattle, WA, USA.
Finfer S; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Imperial College London, London, UK.
Guérin C; University de Lyon, Lyon, France; Institut Mondor de Recherches Biomédicales, Créteil, France.
Hammond NE; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Newton, Adelaide, SA, Australia.
Jaber S; Hôpital Saint-Éloi, Montpellier University Hospital, Montpellier, France.
Kleinpell RM; Vanderbilt University School of Nursing, Vanderbilt University, Nashville, TN, USA.
Koh Y; College of Medicine, University of Ulsan College of Medicine, University of Ulsan, Seoul, South Korea.
Kollef M; Washington University School of Medicine, Washington University, St Louis, MO, USA.
Levy MM; Warren Alpert Medical School, Brown University, Providence, RI, USA.
Machado FR; Hospital Sao Paulo, Universidade Federal de São Paulo, São Paulo, Brazil.
Mancebo J; Hospital de Sant Pau, Barcelona, Spain.
Martin-Loeches I; St James's Hospital, Dublin, Ireland.
Mer M; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa; Faculty of Health Sciences University of the Witwatersrand, Johannesburg, South Africa.
Niederman MS; Weill Cornell Medical Center, New York, NY, USA.
Pelosi P; IRCCS for Oncology and Neurosciences, San Martino Policlinico Hospital, Genoa, Italy; University of Genoa, Genoa, Italy.
Perner A; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Peter JV; Christian Medical College, Vellore, India.
Phua J; Alexandra Hospital, National University Health System, Singapore; National University Hospital, National University Health System, Singapore.
Piquilloud L; University Hospital and University of Lausanne, Lausanne, Switzerland.
Pletz MW; Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Rhodes A; St George's University Hospitals NHS Foundation Trust, London, UK.
Schultz MJ; Amsterdam University Medical Centers, Locatie AMC, Amsterdam, Netherlands; Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Singer M; University College London, London, UK.
Timsit JF; APHP, Hôpital Bichat Medical, IAME, University of Paris, Paris, France.
Venkatesh B; The Wesley Hospital, Brisbane, QLD, Australia.
Vincent JL; Université Libre de Bruxelles, Bruxelles, Belgium.
Welte T; German Center of Lung Research, Hannover, Germany.
Myatra SN; Department of Anaesthesia, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 10. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Regional differences in carbapenem-resistant Klebsiella pneumoniae.
Autorzy :
Wyres K; Department of Infectious Diseases, Monash University, Melbourne, VIC 3004, Australia.
Holt K; Department of Infectious Diseases, Monash University, Melbourne, VIC 3004, Australia; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 09. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Autorzy :
Wang M; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Earley M; The Biostatistics Center, The George Washington University, Rockville, MD, USA.
Chen L; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, USA.
Hanson BM; Division of Infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern School of Medicine at Houston, Houston, TX, USA; Center for Infectious Diseases, UTHealth School of Public Health, Houston, TX, USA.
Yu Y; Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liu Z; Infectious Disease Section, Department of Internal Medicine, Peking Union Medical College Hospital, Beijing, China.
Salcedo S; Servicio de Infectología, Organizacion Clinica General del Norte, Barranquilla, Colombia; Facultad de Ciencias de la Salud, Universidad Simón Bolívar, Barranquilla, Colombia.
Cober E; Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH, USA.
Li L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, China.
Kanj SS; Division of Infectious Disease, American University of Beirut Medical Center, Beirut, Lebanon.
Gao H; Department of Infectious Diseases, Shulan Hangzhou Hospital, Hangzhou, China.
Munita JM; Division of Infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern School of Medicine at Houston, Houston, TX, USA; Millennium Initiative for Collaborative Research On Bacterial Resistance, Santiago, Chile; Instituto de Ciencias e Innovación en Medicina, Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
Ordoñez K; Department of Infectious Diseases, E.S.E Hospital Universitario, San Jorge de Pereira, Pereira, Colombia.
Weston G; Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.
Satlin MJ; Division of Infectious Diseases, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.
Valderrama-Beltrán SL; Infectious Diseases Research Group, School of Medicine, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.
Marimuthu K; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; National Centre for Infectious Diseases, Singapore.
Stryjewski ME; Department of Medicine and Division of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina.
Komarow L; The Biostatistics Center, The George Washington University, Rockville, MD, USA.
Luterbach C; Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.
Marshall SH; Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA.
Rudin SD; Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA.
Manca C; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA.
Paterson DL; Department of Infectious Diseases, University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
Reyes J; Grupo de Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque. Bogotá, Colombia; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque. Bogotá, Colombia.
Villegas MV; Grupo de Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque. Bogotá, Colombia; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque. Bogotá, Colombia.
Evans S; The Biostatistics Center, The George Washington University, Rockville, MD, USA.
Hill C; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Arias R; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Baum K; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Fries BC; Department of Medicine, Division of Infectious Diseases, Stony Brook University, Stony Brook, NY, USA.
Doi Y; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Fujita Health University, Aichi, Japan.
Patel R; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Kreiswirth BN; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, USA.
Bonomo RA; Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA; Department of Medicine, Case Western Reserve University School of Medicine, Case Western Reserve University, Cleveland, OH, USA; Departments of Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Case Western Reserve University, Cleveland, OH, USA; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology, Cleveland, OH, USA.
Chambers HF; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Fowler VG Jr; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Arias CA; Division of Infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern School of Medicine at Houston, Houston, TX, USA; Center for Infectious Diseases, UTHealth School of Public Health, Houston, TX, USA; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque. Bogotá, Colombia.
van Duin D; Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA. Electronic address: .
Pokaż więcej
Corporate Authors :
Multi-Drug Resistant Organism Network Investigators
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 09. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Protective immunity after recovery from SARS-CoV-2 infection.
Autorzy :
Kojima N; Department of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA. Electronic address: .
Klausner JD; Departments of Population Health and Public Health Sciences and Medicine, Keck School of Medicine, University Southern California, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 08. Date of Electronic Publication: 2021 Nov 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
COVID-19 vaccination in pregnancy-number needed to vaccinate to avoid harm.
Autorzy :
Magee LA; Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
von Dadelszen P; Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
Kalafat E; Middle East Technical University, Faculty of Arts and Sciences, Department of Statistics, Ankara, Turkey; Koc University, School of Medicine, Department of Obstetrics and Gynaecology, Istanbul, Turkey.
Duncan EL; Department of Twin Research & Genetic Epidemiology, School of Life Course Sciences, King's College London, London, UK.
O'Brien P; The Royal College of Obstetricians and Gynaecologists, London, UK; University College London Hospitals NHS Foundation Trust, London, UK.
Morris E; The Royal College of Obstetricians and Gynaecologists, London, UK; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK.
Heath P; Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St George's University of London, London SW17 0QT, UK.
Khalil A; Fetal Medicine Unit, St George's Hospital, St George's University of London, London SW17 0QT, UK; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London SW17 0QT, UK. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 02. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Medical countermeasures against henipaviruses: a review and public health perspective.
Autorzy :
Gómez Román R; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Tornieporth N; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway; University of Applied Sciences & Arts, Hanover, Germany.
Cherian NG; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Shurtleff AC; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
L'Azou Jackson M; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Yeskey D; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Hacker A; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Mungai E; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway.
Le TT; Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov 01. Date of Electronic Publication: 2021 Nov 01.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Should infectious diseases be targeted to prevent dementias?
Autorzy :
Bu XL; Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing 400042, China; The Institute of Brain and Intelligence, Third Military Medical University, Chongqing, China; Chongqing Key Laboratory of Ageing and Brain Diseases, Chongqing, China; State Key Laboratory of Trauma, Burn and Combined Injury, Daping Hospital, Third Military Medical University, Chongqing, China.
Wang YJ; Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing 400042, China; The Institute of Brain and Intelligence, Third Military Medical University, Chongqing, China; Chongqing Key Laboratory of Ageing and Brain Diseases, Chongqing, China; State Key Laboratory of Trauma, Burn and Combined Injury, Daping Hospital, Third Military Medical University, Chongqing, China; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov; Vol. 21 (11), pp. 1477-1478. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
Autorzy :
McLean ARD; Medical Action Myanmar, Yangon, Myanmar; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Indrasuta C; Medical Action Myanmar, Yangon, Myanmar.
Khant ZS; Medical Action Myanmar, Yangon, Myanmar.
Phyo AK; Medical Action Myanmar, Yangon, Myanmar.
Maung SM; Medical Action Myanmar, Yangon, Myanmar.
Heaton J; Medical Action Myanmar, Yangon, Myanmar.
Aung H; Medical Action Myanmar, Yangon, Myanmar.
Aung Y; Medical Action Myanmar, Yangon, Myanmar.
Soe K; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Swe MMM; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
von Seidlein L; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Tun NN; Medical Action Myanmar, Yangon, Myanmar; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Tun KM; Department of Preventive and Social Medicine, Defence Services Medical Academy, Yangon, Myanmar.
Day NPJ; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Ashley EA; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Hlaing T; Department of Public Health, Ministry of Health and Sports, Nay Pyi Taw, Myanmar.
Kyaw TT; Department of Public Health, Ministry of Health and Sports, Nay Pyi Taw, Myanmar.
Dondorp AM; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Imwong M; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
White NJ; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Smithuis FM; Medical Action Myanmar, Yangon, Myanmar; Myanmar Oxford Clinical Research Unit, Yangon, Myanmar; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov; Vol. 21 (11), pp. 1579-1589. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.
Autorzy :
Hyams C; Population Health Sciences, University of Bristol, Bristol, UK; Academic Respiratory Unit, Southmead Hospital, Bristol, UK.
Marlow R; Population Health Sciences, University of Bristol, Bristol, UK.
Maseko Z; Academic Respiratory Unit, Southmead Hospital, Bristol, UK.
King J; Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Ward L; North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Fox K; Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Heath R; Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Tuner A; Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Friedrich Z; North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Morrison L; North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Ruffino G; North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Antico R; Population Health Sciences, University of Bristol, Bristol, UK.
Adegbite D; Population Health Sciences, University of Bristol, Bristol, UK.
Szasz-Benczur Z; Population Health Sciences, University of Bristol, Bristol, UK.
Garcia Gonzalez M; Population Health Sciences, University of Bristol, Bristol, UK.
Oliver J; Population Health Sciences, University of Bristol, Bristol, UK.
Danon L; Engineering Mathematics, University of Bristol, Bristol, UK.
Finn A; Population Health Sciences, University of Bristol, Bristol, UK; Cellular and Molecular Medicine, University of Bristol, Bristol, UK. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov; Vol. 21 (11), pp. 1539-1548. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunogenicity, Vaccine*
COVID-19/*prevention & control
COVID-19 Vaccines/*immunology
Hospitalization/*statistics & numerical data
Age Factors ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/virology ; COVID-19 Nucleic Acid Testing/statistics & numerical data ; COVID-19 Vaccines/administration & dosage ; Case-Control Studies ; England/epidemiology ; Female ; Humans ; Immunization Schedule ; Incidence ; Male ; Mass Vaccination/methods ; Mass Vaccination/statistics & numerical data ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; SARS-CoV-2/isolation & purification ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination - Authors' reply.
Autorzy :
Wong ICK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Expert Committee on Clinical Events Assessment Following COVID-19 Immunization, Department of Health, Government of the Hong Kong SAR, Hong Kong SAR, China; Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK. Electronic address: .
Wan EYF; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China.
Chui CSL; School of Nursing, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China.
Li X; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China.
Chan EWY; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Nov; Vol. 21 (11), pp. 1492-1493.
Typ publikacji :
Letter; Comment
MeSH Terms :
Bell Palsy*/etiology
COVID-19*
COVID-19 Vaccines ; Humans ; SARS-CoV-2 ; Vaccination/adverse effects
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies